198 related articles for article (PubMed ID: 31559188)
1. Correlation between ADC values and Gleason score in evaluation of prostate cancer: multicentre experience and review of the literature.
Manetta R; Palumbo P; Gianneramo C; Bruno F; Arrigoni F; Natella R; Maggialetti N; Agostini A; Giovagnoni A; Di Cesare E; Splendiani A; Masciocchi C; Barile A
Gland Surg; 2019 Sep; 8(Suppl 3):S216-S222. PubMed ID: 31559188
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Diffusion Kurtosis Imaging Versus Standard Diffusion Imaging for Detection and Grading of Peripheral Zone Prostate Cancer.
Roethke MC; Kuder TA; Kuru TH; Fenchel M; Hadaschik BA; Laun FB; Schlemmer HP; Stieltjes B
Invest Radiol; 2015 Aug; 50(8):483-9. PubMed ID: 25867657
[TBL] [Abstract][Full Text] [Related]
3. Multiparametric MRI in detection and staging of prostate cancer.
Boesen L
Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
[TBL] [Abstract][Full Text] [Related]
4. Application evaluation of DCE-MRI combined with quantitative analysis of DWI for the diagnosis of prostate cancer.
Ma XZ; Lv K; Sheng JL; Yu YX; Pang PP; Xu MS; Wang SW
Oncol Lett; 2019 Mar; 17(3):3077-3084. PubMed ID: 30867737
[TBL] [Abstract][Full Text] [Related]
5. Noninferiority of Monoparametric MRI Versus Multiparametric MRI for the Detection of Prostate Cancer: Diagnostic Accuracy of ADC Ratios Based on Advanced "Zoomed" Diffusion-Weighted Imaging.
Raczeck P; Frenzel F; Woerner T; Graeber S; Bohle RM; Ziegler G; Buecker A; Schneider GK
Invest Radiol; 2022 Apr; 57(4):233-241. PubMed ID: 34743133
[TBL] [Abstract][Full Text] [Related]
6. The value of ADC, T2 signal intensity, and a combination of both parameters to assess Gleason score and primary Gleason grades in patients with known prostate cancer.
Nowak J; Malzahn U; Baur AD; Reichelt U; Franiel T; Hamm B; Durmus T
Acta Radiol; 2016 Jan; 57(1):107-14. PubMed ID: 25505225
[TBL] [Abstract][Full Text] [Related]
7. Differentiation of prostate cancer lesions in the Transition Zone by diffusion-weighted MRI.
Bao J; Wang X; Hu C; Hou J; Dong F; Guo L
Eur J Radiol Open; 2017; 4():123-128. PubMed ID: 29034282
[TBL] [Abstract][Full Text] [Related]
8. Diffusion Kurtosis Imaging Combined With DWI at 3-T MRI for Detection and Assessment of Aggressiveness of Prostate Cancer.
Wang X; Tu N; Qin T; Xing F; Wang P; Wu G
AJR Am J Roentgenol; 2018 Oct; 211(4):797-804. PubMed ID: 30085835
[TBL] [Abstract][Full Text] [Related]
9. Multiparametric MRI in the Diagnosis of Prostate Cancer: Physical Foundations, Limitations, and Prospective Advances of Diffusion-Weighted MRI.
Wichtmann BD; Zöllner FG; Attenberger UI; Schönberg SO
Rofo; 2021 Apr; 193(4):399-409. PubMed ID: 33302312
[TBL] [Abstract][Full Text] [Related]
10. The Utility of Diffusion Weighted Imaging (DWI) Using Apparent Diffusion Coefficient (ADC) Values in Discriminating Between Prostate Cancer and Normal Tissue.
Luczyńska E; Heinze-Paluchowska S; Domalik A; Cwierz A; Kasperkiewicz H; Blecharz P; Jereczek-Fossa B
Pol J Radiol; 2014; 79():450-5. PubMed ID: 25484999
[TBL] [Abstract][Full Text] [Related]
11. Intravoxel Incoherent Motion (IVIM) Diffusion Weighted Imaging (DWI) in the Periferic Prostate Cancer Detection and Stratification.
Pesapane F; Patella F; Fumarola EM; Panella S; Ierardi AM; Pompili GG; Franceschelli G; Angileri SA; Magenta Biasina A; Carrafiello G
Med Oncol; 2017 Mar; 34(3):35. PubMed ID: 28144814
[TBL] [Abstract][Full Text] [Related]
12. Apparent diffusion coefficient values are superior to transrectal ultrasound-guided prostate biopsy for the assessment of prostate cancer aggressiveness.
Li C; Chen M; Wang J; Wang X; Zhang W; Zhang C
Acta Radiol; 2017 Feb; 58(2):232-239. PubMed ID: 27055916
[TBL] [Abstract][Full Text] [Related]
13. Correlation of Gleason scores with diffusion-weighted imaging findings of prostate cancer.
Nagarajan R; Margolis D; Raman S; Sheng K; King C; Reiter R; Thomas MA
Adv Urol; 2012; 2012():374805. PubMed ID: 22216026
[TBL] [Abstract][Full Text] [Related]
14. Multiparametric MRI Apparent Diffusion Coefficient (ADC) Accuracy in Diagnosing Clinically Significant Prostate Cancer.
Pepe P; D'Urso D; Garufi A; Priolo G; Pennisi M; Russo G; Sabini MG; Valastro LM; Galia A; Fraggetta F
In Vivo; 2017; 31(3):415-418. PubMed ID: 28438871
[TBL] [Abstract][Full Text] [Related]
15. Risk Stratification of Prostate Cancer Using the Combination of Histogram Analysis of Apparent Diffusion Coefficient Across Tumor Diffusion Volume and Clinical Information: A Pilot Study.
Zhang Z; Xu H; Xue Y; Li J; Ye Q
J Magn Reson Imaging; 2019 Feb; 49(2):556-564. PubMed ID: 30173421
[TBL] [Abstract][Full Text] [Related]
16. Conventional vs. reduced field of view diffusion weighted imaging of the prostate: Comparison of image quality, correlation with histology, and inter-reader agreement.
Warndahl BA; Borisch EA; Kawashima A; Riederer SJ; Froemming AT
Magn Reson Imaging; 2018 Apr; 47():67-76. PubMed ID: 29103977
[TBL] [Abstract][Full Text] [Related]
17. Diffusion-weighted MRI of peripheral zone prostate cancer: comparison of tumor apparent diffusion coefficient with Gleason score and percentage of tumor on core biopsy.
Woodfield CA; Tung GA; Grand DJ; Pezzullo JA; Machan JT; Renzulli JF
AJR Am J Roentgenol; 2010 Apr; 194(4):W316-22. PubMed ID: 20308476
[TBL] [Abstract][Full Text] [Related]
18. Initial experience with identifying high-grade prostate cancer using diffusion-weighted MR imaging (DWI) in patients with a Gleason score ≤ 3 + 3 = 6 upon schematic TRUS-guided biopsy: a radical prostatectomy correlated series.
Somford DM; Hambrock T; Hulsbergen-van de Kaa CA; Fütterer JJ; van Oort IM; van Basten JP; Karthaus HF; Witjes JA; Barentsz JO
Invest Radiol; 2012 Mar; 47(3):153-8. PubMed ID: 22293513
[TBL] [Abstract][Full Text] [Related]
19. Quantitative evaluation of the relative apparent diffusion coefficient values on multiparametric magnetic resonance imaging to predict higher Gleason score prostate cancer.
Kato S; Kamijima S; Inaoka T; Kamiya N; Sasai D; Terada H; Hiruta N; Suzuki H
Scand J Urol; 2018 Jun; 52(3):180-185. PubMed ID: 29939084
[TBL] [Abstract][Full Text] [Related]
20. Can DW-MRI, with its ADC values, be a reliable predictor of biopsy outcome in patients with suspected prostate cancer?
Faletti R; Battisti G; Discalzi A; Grognardi ML; Martinello S; Oderda M; Gontero P; Bergamasco L; Cassinis MC; Fonio P
Abdom Radiol (NY); 2016 May; 41(5):926-33. PubMed ID: 27193791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
